As of Jan 10, 2025, Incyte Corporation Intrinsic Value is $77.6. This suggests it may be undervalued by 10.1% compared to its current price of around $70.5.
As of Jan 10, 2025, Incyte Corporation's Discounted Cash Flow (DCF) valuation estimates its share price at $72.7. This suggests it may be overvalued by 3.2% to its current price of around $70.5, using a discount rate of 8.0% and terminal growth rate of 3.0%.
Incyte Corporation is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $77.6, compared to a market price of around $70.5. This suggests a potential undervaluation of 10.1%.